Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cees J Tack

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed micePatricia M Nunes, Alan J Wright, Andor Veltien, et al.
Pharmacogenetics and Genomics|March 13, 2008
The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitusBas J Schouwenberg, Bart A Veldman, Wilko Spiering, et al.
Expert Review of Proteomics|November 24, 2018
The future of protein biomarker research in type 2 diabetes mellitusRoel Tans, Lars Verschuren, Hans J C T Wessels, et al.
Diabetes|April 28, 2005
Glycogen synthesis in human gastrocnemius muscle is not representative of whole-body muscle glycogen synthesisMireille J M Serlie, Jacco H de Haan, Cees J Tack, et al.
Clinical Therapeutics|March 6, 2018
Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII TreatmentLian A van Meijel, Sandra P van den Heuvel-Bens, Lisa J Zimmerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2006
Transport within the interstitial space, rather than membrane permeability, determines norepinephrine recovery in microdialysisH Alec Ross, Petra J van Gurp, Jacques J Willemsen, et al.
Diabetologia|March 6, 2023
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM studyLinda C A Drenthen, Mandala Ajie, Evertine J Abbink, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed micePatricia M Nunes, Alan J Wright, Andor Veltien, et al.
Pharmacogenetics and Genomics|March 13, 2008
The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitusBas J Schouwenberg, Bart A Veldman, Wilko Spiering, et al.
Expert Review of Proteomics|November 24, 2018
The future of protein biomarker research in type 2 diabetes mellitusRoel Tans, Lars Verschuren, Hans J C T Wessels, et al.
Diabetes|April 28, 2005
Glycogen synthesis in human gastrocnemius muscle is not representative of whole-body muscle glycogen synthesisMireille J M Serlie, Jacco H de Haan, Cees J Tack, et al.
Clinical Therapeutics|March 6, 2018
Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII TreatmentLian A van Meijel, Sandra P van den Heuvel-Bens, Lisa J Zimmerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2006
Transport within the interstitial space, rather than membrane permeability, determines norepinephrine recovery in microdialysisH Alec Ross, Petra J van Gurp, Jacques J Willemsen, et al.
Diabetologia|March 6, 2023
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM studyLinda C A Drenthen, Mandala Ajie, Evertine J Abbink, et al.
Pageof 19